Furnaces & Ovens


Fisher Scientific Muffle Furnace

Fisher Scientific 750 Programmable Muffle Furnace

The Fisher 750 programmable muffle furnace offers working temperatures from 50 to 1125 °C, ideal for bonding glass devices and annealing materials. The PID controller holds up to four programs, each allowing up to 24 steps for ramp rates and soak times. The chamber volume is 0.58 ft3, and is plumbed with nitrogen for an inert atmosphere.

Reserve the Muffle Furnace


Lindberg/Blue M 3-Zone Tube Furnace

Lindberg/Blue M 3-Zone Tube Furnace

The Lindberg/Blue M 3-zone tube furnace (STF55346C; 3.8 kW) offers working temperatures from room temp to 1100 °C. The UP150 PID controllers provide stepped program control for multiple ramp rate steps and soak times. The tube is 3" in diameter and 34" in length, and is plumbed with nitrogen for an inert atmosphere.


Blue M Stabil-Therm Oven

Blue M Stabil-Therm Oven

The Blue M Stabil-Therm gravity oven (OV-8A X; 500 W) offers working temperatures from room temp to 260 °C, and is used for photolithographic processes. The retrofitted Auber PID controller is easy to use, and provides accurate temperature control with fast ramp rates and minimal overshoot. The chamber volume is 0.30 ft3.

To reserve the Blue M Stabil-Therm Oven located in the Photolithography Room, click here.


Lindberg/Blue M Oven

Lindberg/Blue M Gravity Oven

The Lindberg/Blue M gravity oven (GO1305A-1; 750 W) offers working temperatures from 40 to 200 °C, and is currently being used to cure PDMS. The PID controller is easy to use, and provides accurate temperature control with fast ramp rates and minimal overshoot. The chamber volume is 2.00 ft3.


CMADP Upcoming Events

Special seminar by Dr. Kevin W. Plaxco
Professor of Chemistry & Biochemistry
UC Santa Barbara

Wednesday, April 19, 2017 at 4:00pm
School of Pharmacy, Room 3020

"Counting molecules, dodging blood cells: real-time molecular measurements directly in the living body"
The development of technology capable of continuously tracking the levels of drugs, metabolites, and biomarkers in situ in the body would revolutionize our understanding of health and our ability to detect and treat disease. It would, for example, provide clinicians with a real-time window into organ function and would enable therapies guided by patient-specific, real-time pharmacokinetics, opening a new dimension in personalized medicine. In response my group has pioneered the development of a “biology-inspired” electrochemical approach to monitoring specific molecules that supports real-time measurements of arbitrary molecular targets (irrespective of their chemical reactivity) directly in awake, fully ambulatory subjects.
KU Today